{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T03:23:44Z","timestamp":1781580224622,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:00:00Z","timestamp":1542931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s11239-018-1775-2","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T10:25:24Z","timestamp":1542968724000},"page":"292-300","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Direct oral anticoagulants in the early phase of non valvular atrial fibrillation-related acute ischemic stroke: focus on real life studies"],"prefix":"10.1007","volume":"47","author":[{"given":"Luca","family":"Masotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Grifoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Dei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vieri","family":"Vannucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Panigada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Spolveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Landini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,23]]},"reference":[{"key":"1775_CR1","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","volume":"49","author":"WJ Powers","year":"2018","unstructured":"Powers WJ, Rabinstein AA, Ackerson T et al (2018) 2018 guidelines for the early management of patients with acute ischemic stroke. A guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 49:e46\u2013e110","journal-title":"Stroke"},{"key":"1775_CR2","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2009","unstructured":"Hart RG, Pearce LA, Aguilar MI (2009) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146:857\u2013867","journal-title":"Ann Intern Med"},{"key":"1775_CR3","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/ene.12577","volume":"22","author":"AH Abdul-Rahim","year":"2015","unstructured":"Abdul-Rahim AH, Fulton RL, Frank B, VISTA collaborators et al (2015) Association of improved outcome in acute ischaemic stroke patients with atrial fibrillation who receive early antithrombotic therapy: analysis from VISTA. Eur J Neurol 22:1048\u20131055","journal-title":"Eur J Neurol"},{"key":"1775_CR4","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1161\/STROKEAHA.115.008891","volume":"46","author":"M Paciaroni","year":"2015","unstructured":"Paciaroni M, Agnelli G, Falocci N et al (2015) Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: effect of anticoagulation and its timing: the RAF study. Stroke 46:2175\u20132182","journal-title":"Stroke"},{"key":"1775_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1177\/1747493017700663","volume":"12","author":"G Ntaios","year":"2017","unstructured":"Ntaios G, Papavasileiou V, Diener HC, Makaritsis K, Michel P (2017) Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized controlled trials. Int J Stroke 12:589\u2013596","journal-title":"Int J Stroke"},{"key":"1775_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4081\/itjm.2013.s8.8","volume":"7","author":"L Masotti","year":"2013","unstructured":"Masotti L, Di Napoli M, Ageno W et al (2013) Direct oral anticoagulants for secondary prevention in patients with non valvular atrial fibrillation. Ital J Med 7:8\u201321","journal-title":"Ital J Med"},{"key":"1775_CR7","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/ggi.13453","volume":"18","author":"L Masotti","year":"2018","unstructured":"Masotti L, Moroni F, Vannucchi V, Grifoni E, Dei A, Landini G (2018) Direct oral anticoagulants in the early phase of non-valvular atrial fibrillation-related ischemic stroke in very old patients undergoing systemic thrombolysis and\/or mechanical thrombectomy. Geriatr Gerontol Int 18:1304\u20131305","journal-title":"Geriatr Gerontol Int"},{"key":"1775_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.08.001","volume":"27","author":"F Moroni","year":"2018","unstructured":"Moroni F, Masotti, Vannucchi V et al (2018) Confidence in use of direct oral anticoagulants in the acute phase of non valvular atrial fibrillation-related ischemic stroke over the years: a real world single centre study. J Stroke Cerebrovasc Dis 27:76\u201382","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1775_CR9","first-page":"1093","volume":"5","author":"T Nakase","year":"2017","unstructured":"Nakase T, Ishikawa T (2017) The introduction time of oral anticoagulants in the early phase of acute stroke patients. J cardiol Clin Res 5:1093","journal-title":"J cardiol Clin Res"},{"key":"1775_CR10","doi-asserted-by":"publisher","unstructured":"Paciaroni M, Agnelli G, Falocci N et al (2017) Early recurrence and major bleeding in patients with acute ischemic Stroke and atrial fibrillation treated with non-vitamin-K oral anticoagulants (RAF-NOACs) study. J Am Heart Assoc 6(12). \n                    https:\/\/doi.org\/10.1161\/JAHA.117.007034","DOI":"10.1161\/JAHA.117.007034"},{"key":"1775_CR11","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/1747493016632239","volume":"11","author":"S Arihiro","year":"2016","unstructured":"Arihiro S, Todo K, Koga M, SAMURAI study investigators et al (2016) Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: the SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study. Int J Stroke 11:565\u2013574","journal-title":"Int J Stroke"},{"key":"1775_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s11239-016-1393-9","volume":"42","author":"M Cappellari","year":"2016","unstructured":"Cappellari M, Carletti M, Danese A, Bovi P (2016) Early introduction of direct oral anticoagulants in cardioembolic stroke patients with non-valvular atrial fibrillation. J Thromb Thrombolysis 42:393\u2013398","journal-title":"J Thromb Thrombolysis"},{"key":"1775_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1253\/circj.CJ-16-0923","volume":"81","author":"I Deguchi","year":"2017","unstructured":"Deguchi I, Tanahashi N, Takao M (2017) Timing of treatment initiation with oral anticoagulants for acute ischemic stroke in patients with nonvalvular atrial fibrillation. Circ J 81:180\u2013184","journal-title":"Circ J"},{"key":"1775_CR14","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1161\/STROKEAHA.116.013491","volume":"47","author":"LC Gioia","year":"2016","unstructured":"Gioia LC, Kate M, Sivakumar L, Hussain D et al (2016) Early rivaroxaban use after cardioembolic stroke may not result in hemorrhagic transformation: a prospective magnetic resonance imaging study. Stroke 47:1917\u20131919","journal-title":"Stroke"},{"key":"1775_CR15","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.06.031","volume":"25","author":"K Macha","year":"2016","unstructured":"Macha K, Volbers B, Bobinger T et al (2016) Early initiation of anticoagulation with direct oral anticoagulants in patients after transient ischemic attack or ischemic stroke. J Stroke Cerebrovasc Dis 25:2317\u20132321","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1775_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11239-016-1376-x","volume":"42","author":"N Saji","year":"2016","unstructured":"Saji N, Kimura K, Tateishi Y et al (2016) Safety and efficacy of non vitamin K oral anticoagulant treatment compared with warfarin in patients with non valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci study). J Thromb Thrombolysis 42:453\u2013462","journal-title":"J Thromb Thrombolysis"},{"key":"1775_CR17","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1212\/WNL.0000000000003283","volume":"87","author":"DJ Seiffge","year":"2016","unstructured":"Seiffge DJ, Traenka C, Polymeris A et al (2016) Early start of DOAC after ischemic stroke: risk of intracranial hemorrhage and recurrent events. Neurology 87:1856\u20131862","journal-title":"Neurology"},{"key":"1775_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2217\/fnl.15.43","volume":"10","author":"M Monteagudo","year":"2015","unstructured":"Monteagudo M, Fernandez-Diaz E, Garcia-Garcia J, Ayo-Martin O, Hernandez-Fernandez F, Segura T (2015) Efficacy, safety and tolerability of rivaroxaban for the secondary prevention of stroke in patients with atrial fibrillation in clinical practice. Future Neurol 10:529\u2013536","journal-title":"Future Neurol"},{"key":"1775_CR19","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1253\/circj.CJ-14-0793","volume":"79","author":"E Nomura","year":"2015","unstructured":"Nomura E, Ohshita T, Imamura E et al (2015) Early administration of non-vitamin K antagonist oral anticoagulants for acute ischemic stroke patients with atrial fibrillation in comparison with warfarin mostly combined with heparin. Circ J 79:862\u2013866","journal-title":"Circ J"},{"key":"1775_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.neurol.2015.02.012","volume":"171","author":"T Ritzenthaler","year":"2015","unstructured":"Ritzenthaler T, Derex L, Davenas C et al (2015) Safety of early initiation of rivaroxaban and dabigatran after thrombolysis in acute ischemic stroke. Revue Neurologique 171:613\u2013615","journal-title":"Revue Neurologique"},{"key":"1775_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jns.2013.05.016","volume":"331","author":"K Shibazaki","year":"2013","unstructured":"Shibazaki K, Kimura K, Aoki J, Saji N, Sakai K (2013) Early initiation of new oral anticoagulants in acute stroke and TIA patients with nonvalvular atrial fibrillation. J Neurol Sci 331:90\u201393","journal-title":"J Neurol Sci"},{"key":"1775_CR22","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E, ENGAGE AF-TIMI 48 Investigators et al (2013) Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369:2093\u20132104","journal-title":"N Engl J Med"},{"key":"1775_CR23","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Eng J Med 361:1139\u20131151","journal-title":"N Eng J Med"},{"key":"1775_CR24","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, ROCKET AF Investigators et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883\u2013891","journal-title":"N Engl J Med"},{"key":"1775_CR25","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, ARISTOTLE Committees and Investigators et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981\u2013992","journal-title":"N Engl J Med"},{"key":"1775_CR26","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamaneurol.2017.2161","volume":"74","author":"KS Hong","year":"2017","unstructured":"Hong KS, Kwon SU, Lee SH, Phase 2 exploratory clinical study to assess the effects of xarelto (Rivaroxaban) versus warfarin on ischemia, bleeding, and hospital stay in acute cerebral infarction patients with non-valvular atrial fibrillation (Triple AXEL) Study Group et al (2017) Rivaroxaban vs warfarin sodium in the ultra-early Period after atrial fibrillation-related mild ischemic stroke: a randomized clinical trial. JAMA Neurol 74:1206\u20131215","journal-title":"JAMA Neurol"},{"key":"1775_CR27","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","volume":"39","author":"J Steffel","year":"2018","unstructured":"Steffel J, Verhamme P, Potpara TS et al, ESC Scientific Document Group (2018) The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 39:1330\u20131393","journal-title":"Eur Heart J"},{"key":"1775_CR28","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1253\/circj.CJ-18-0067","volume":"82","author":"S Yoshimura","year":"2018","unstructured":"Yoshimura S, Koga M, Sato S, SAMURAI Study Investigators et al (2018) Two-year outcomes of anticoagulation for acute ischemic stroke with nonvalvular atrial fibrillation- SAMURAI-NVAF Study. Circ J 82:1935\u20131942","journal-title":"Circ J"},{"key":"1775_CR29","doi-asserted-by":"crossref","unstructured":"Yasaka M, Minematsu K, Toyoda K et al (2016) Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study. J Stroke Cerebrovasc Dis 25:1342-1348. ClinicalTrials.gov Identifier: NCT02129920","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.01.035"},{"key":"1775_CR30","unstructured":"Early Administration of Edoxaban After Acute ischemic stroke in patients with non-valvular atrial fibrillation. ClinicalTrials.gov Identifier: NCT03433235"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-018-1775-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-018-1775-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-018-1775-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T00:27:37Z","timestamp":1574468857000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-018-1775-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,23]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1775"],"URL":"https:\/\/doi.org\/10.1007\/s11239-018-1775-2","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,23]]},"assertion":[{"value":"23 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"We declare that all the Authors have read and approved the final version of the manuscript entitle \u201cDirect oral anticoagulants in the early phase of non valvular atrial fibrillation-related acute ischemic stroke: focus on real life studies\u201d and we have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The paper is an overview of already published real life studies on the use of Direct Oral Anticoagulants in the early phase of stroke in humans","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Research involving human participants and\/<!--Emphasis Type='Bold' removed-->or animals"}},{"value":"It is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}